Coeptis Therapeutics Hits Day High with Strong 7.31% Intraday Surge

Coeptis Therapeutics Holdings, Inc. has experienced a significant uptick in its stock performance, gaining 7.31% on June 18, 2026. The stock reached an intraday high of USD 16.85, reflecting a strong day of trading for the small-cap company in the Pharmaceuticals & Biotechnology sector. Over the past week, Coeptis has shown remarkable growth, with a performance increase of 53.49%, and an impressive 78.36% rise over the past month. Year-to-date, the stock has risen by 17.4%, significantly outperforming the S&P 500, which has seen a return of 9.57% during the same period. Despite the positive short-term performance, the company has reported losses, with a negative return on equity of 0%. However, it has shown a notable increase in net sales, growing by 1,452.02% to USD 0.98 million. Institutional investors have also increased their stakes in the company, now holding 17.36% of shares, indicating a growing interest in Coeptis's potential. Overall, the stock's recent performance highlights its volatility and the dynamic nature of its market position.